Cytori Therapeutics (CYTX -0.7%) says that an investigator-sponsored and funded clinical study...

|About: Cytori Therapeutics Inc (CYTX)|By:, SA News Editor

Cytori Therapeutics (CYTX -0.7%) says that an investigator-sponsored and funded clinical study evaluating it's cell therapy as a potential treatment for scleroderma has been approved to begin in France by the National Agency for the Safety of Medicines and Health Products.